Photodynamic effect of 5-aminolevulinic acid-loaded nanoparticles on bladder cancer cells: A preliminary investigation

Scandinavian Journal of Urology

Volumn 47, Issue 2, 2013, Pages 145-151

  Yan, Xiang ^a   Al Hayek, Samih ^b   Huang, Haifeng ^a   Zhu, Zhenshu ^c   Zhu, Wei ^a   Guo, Hongqian ^a  

^a NANJING UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bladder cancer; Nanoparticles; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; NANOPARTICLE; POLYMER;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CYTOTOXICITY; DIODE LASER; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY;

AMINOLEVULINIC ACID; CELL LINE, TUMOR; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84875437898     PISSN: 21681805     EISSN: 21681813     Source Type: Journal    
DOI: 10.3109/00365599.2012.713000     Document Type: Article

References (31)

1. Alexiades-Armenakas M. Laser-mediated photodynamic therapy. Clin Dermatol 2006;24:16-25.
2. Jezek P, Nekvasil M, Skobisová E, Urbánková E, Jirsa M, Zadinová M, et al. Experimental photodynamic therapy with MESO-tetrakisphenylporphyrin (TPP) in liposomes leads to disintegration of human amelanotic melanoma implanted to nude mice. Int J Cancer 2003;103:693-702.
3. Kolarova H, Nevrelova P, Bajgar R, Jirova D, Kejlova K, Strnad M. In vitro photodynamic therapy on melanoma cell lines with phthalocyanine. Toxicol In Vitro 2007;21: 249-53.
4. Juzeniene A, Peng Q, Moan J. Milestones in the development of photodynamic therapy and fluorescence diagnosis. Photochem Photobiol Sci 2007;6:1234-45.
5. Kabingu E, Oseroff AR,Wilding GE, Gollnick SO. Enhanced systemic immune reactivity to a basal cell carcinoma associated antigen following photodynamic therapy. Clin Cancer Res 2009;15:4460-6.
6. Tang PM, Zhang DM, Xuan NH, Tsui SK, Waye MM, Kong SK, et al. Photodynamic therapy inhibits p-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a. Mol Cancer 2009;8:56.
7. Nowak-Sliwinska P, van Beijnum JR, van Berkel M, van den Bergh H, Griffioen AW. Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane. Angiogenesis 2010;13:281-92.
8. Kruijt B, de Bruijn HS, van der Ploeg-van den Heuvel A, Sterenborg HJ, Robinson DJ. Laser speckle imaging of dynamic changes in flow during photodynamic therapy. Lasers Med Sci 2006;21:208-12.
9. Babilas P, Landthaler M, Szeimies RM. Photodynamic therapy in dermatology. Eur J Dermatol 2006;16:340-8.
10. Casas A, Batlle A. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy. Curr Med Chem Anticancer Agents 2002;2:465-75.
11. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990; 6:143-8.
12. Kloek J, Beijersbergen van Henegouwen Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 1996;64:994-1000.
13. Ding D, Zhu Z, Li R, Li X, Wu W, Jiang X, et al. Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system. ACS Nano 2011;5:2520-34.
14. Zhang L, Yang M, Wang Q, Li Y, Guo R, Jiang X, et al. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice. J Control Release 2007;119: 153-62.
15. Holmäng S, Hedelin H, Anderström C, Holmberg E, Busch C, Johansson SL. Recurrence and progression in low grade papillary urothelial tumors. J Urol 1999; 162:702-7.
16. Divrik RT, Yildirim U, Zorlu F, Ozen H. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. J Urol 2006;175:1641-4.
17. Schwaibold HE, Sivalingam S, May F, Hartung R. The value of a second transurethral resection for T1 bladder cancer. BJU Int 2006;97:1199-201.
18. Skyrme RJ, French AJ, Datta SN, Allman R, Mason MD, Matthews PN. A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma. BJU Int 2005; 95:1206-10.
19. Parekh DJ, Bochner BH, Dalbagni G. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments. J Clin Oncol 2006;24:5519-27.
20. Dougherty TJ. Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol 1984;2:83-116.
21. Fotinos N, Campo MA, Popowycz F, Gurny R, Lange N. 5-Aminolevulinic acid derivatives in photomedicine: characteristics, application and perspectives. Photochem Photobiol 2006;82:994-1015.
22. Kamuhabwa AR, Huygens A, Roskams T, De Witte PA. Enhancing the photodynamic effect of hypericin in human bladder transitional cell carcinoma spheroids by the use of the oxygen carrier, perfluorodecalin. Int J Oncol 2006; 28:775-80.
23. Pervaiz S, OlivoM. Art and science of photodynamic therapy. Clin Exp Pharmacol Physiol 2006;33:551-6.
24. Brown SB, Mellish KJ. Verteporfin: a milestone in ophthalmology and photodynamic therapy. Expert Opin Pharmacother 2001;2:351-61.
25. Detty MR, Gibson SL, Wagner SJ. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 2004;47:3897-915.
26. Stockert JC,CañeteM, JuarranzA, VillanuevaA,HorobinRW, Borrell JI, et al. Porphycenes: facts and prospects in photodynamic therapy of cancer. CurrMed Chem 2007;14:997-1026.
27. Kauppinen R. Porphyrias. Lancet 2005;365:241-52.
28. Schmidbauer J, Witjes F, Schmeller N, Donat R, Susani M, Marberger M, et al. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol 2004;171:135-8.
29. Faraji AH, Wipf P. Nanoparticles in cellular drug delivery. Bioorg Med Chem 2009;17:2950-62.
30. Gaullier JM, Berg K, Peng Q, Anholt H, Selbo PK, Ma LW, et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 1997; 57:1481-6.
31. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 2001; 41:189-207.